Odyssey Therapeutics (ODTX) officer reports 78,958-share stock option holding
Rhea-AI Filing Summary
Odyssey Therapeutics, Inc. insider Jolie Siegel reported existing derivative holdings on a Form 3. The filing shows a stock option to buy common stock with an exercise price of $5.15 per share for 78,958 underlying shares, expiring on March 11, 2036. According to the vesting terms, 25% of this option will vest on January 12, 2027, with the rest vesting in 36 equal monthly installments, contingent on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Siegel Jolie
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 78,958 shares (Direct)
Footnotes (1)
- F1. 25% of the option will vest on January 12, 2027, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
Underlying option shares: 78,958 shares
Exercise price: $5.15 per share
Expiration date: March 11, 2036
+2 more
5 metrics
Underlying option shares
78,958 shares
Stock Option (Right to Buy) on common stock
Exercise price
$5.15 per share
Stock option strike price
Expiration date
March 11, 2036
Option expiration
Initial vesting portion
25%
Vests on January 12, 2027
Remaining vesting schedule
36 monthly installments
After January 12, 2027, subject to continued service
Key Terms
Stock Option (Right to Buy), underlying security, exercise price, vesting
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
underlying security financial
"underlying_security_title: Common Stock"
exercise price financial
"conversion_or_exercise_price: 5.1500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the option will vest on January 12, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Odyssey Therapeutics (ODTX) Form 3 for Jolie Siegel report?
The Form 3 for Odyssey Therapeutics (ODTX) reports Jolie Siegel’s existing stock option holding. It covers an option to buy 78,958 shares of common stock at an exercise price of $5.15 per share, expiring on March 11, 2036.
What is the exercise price of Jolie Siegel’s Odyssey Therapeutics (ODTX) option?
The exercise price of Jolie Siegel’s Odyssey Therapeutics stock option is $5.15 per share. This is the fixed price at which she may buy the underlying common shares once portions of the option vest under the disclosed schedule.
When does Jolie Siegel’s Odyssey Therapeutics (ODTX) option start vesting?
According to the filing footnote, 25% of Jolie Siegel’s option will vest on January 12, 2027. The remaining 75% then vests in 36 equal monthly installments, subject to her continued service with Odyssey Therapeutics on each vesting date.
Is the Odyssey Therapeutics (ODTX) Form 3 a stock purchase or sale by Jolie Siegel?
The Odyssey Therapeutics Form 3 does not show a stock purchase or sale by Jolie Siegel. It reports a stock option holding, giving her the right to buy 78,958 shares at $5.15 per share if and when the option vests and is exercised.
What is the expiration date of Jolie Siegel’s Odyssey Therapeutics (ODTX) stock option?
The reported stock option held by Jolie Siegel expires on March 11, 2036. After this expiration date, any unexercised portion of the option will lapse, meaning she would no longer be able to purchase shares under this particular grant.